medRxivGenetic & Genomic MedicinePreprint
Rare bi-allelic loss-of-function variants in the LRRK2 kinase cause interstitial lung disease
Tuğba KalaycıiD, Kathryn A. Wikenheiser‐BrokampiD, Sara GomesiD, Eshaan S. RawatiD, Anna L. PeljtoiD, Anthea CheungiD, Sevinç ÇitakiD, Mustafa VayvadaiD, Ángeles Montero, Nesrin MoğulkoçiD, N. Gulfer Okumus, İlknur SüeriD, Joseph A. KitzmilleriD, Cheng-Lun NaiD, Xinyuan LiiD, Sheila M. BelliD, Kathleen C.S. CookiD, Monther Abu-RemailehiD, David A. SchwartziD, Zehra Oya UyguneriD, Jeffrey A. WhitsettiD, Dario R. AlessiiD, Alexander ZimprichiD, William J. ZachariasiD, Esther M. SammleriD
Abstract
We report that biallelic LRRK2 loss-of-function (LoF) causes a Mendelian form of interstitial lung disease characterized by alveolar epithelial cell dysfunction and lung fibrosis in two brothers with a homozygous nonsense variant. Integrated clinical, imaging, histopathological, and biomarker analyses showed absent LRRK2 protein, reduced Rab10 phosphorylation, impaired alveolar type 2 cell function, and disrupted surfactant homeostasis. Consistent with a recessive genetic disorder, heterozygous LoF carriers have not been reported to have a lung phenotype. Additional biallelic LRRK2 LoF cases were identified in ILD cohorts, linking LRRK2 LoF to lung disease, in contrast to heterozygous activating missense variants that cause Parkinsons disease (PD).
- organism: human
- assay: bulk RNA-seq
- research focus: differential expression
- research focus: gene regulatory network inference
- approach: statistical model
- Citations
- 0
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Functional analyses of two novel LRRK2 pathogenic variants in familial Parkinson's disease
Ilda Coku, Eugénie Mutez, … Vincent Huin·Movement DisordersPeer-reviewed·Jun 16, 2022
- Parkinson's disease-associated LRRK2 risk variant, G2385R, enhances Rab substrate phosphorylation and impairs neuronal integrity
An Phu Tran Nguyen, Roger Moser, … Darren J. Moore·Human Molecular GeneticsPeer-reviewed·Jan 1, 2026
- LRRK2 exonic variants associated with Parkinson’s disease augment phosphorylation levels for LRRK2-Ser1292 and Rab10-Thr73
Kenneth V. Christensen, Morten Hentzer, … Garrick P. Smith·bioRxiv·Oct 22, 2018
- LRRK2 kinase inhibitors induce a reversible effect in the lungs of non-human primates with no measurable pulmonary deficits
Marco A.S. Baptista, Kalpana Merchant, … Todd B. Sherer·bioRxiv·Aug 15, 2018
- Negative screening for 12 rare LRRK2 pathogenic variants in a cohort of Nigerians with Parkinson disease
Mie Rizig, Oluwadamilola Omolara Ojo, … Njideka Ulunma Okubadejo·Neurobiology of AgingPeer-reviewed·Oct 1, 2020
- Patient-specific iPSCs carrying an SFTPC mutation reveal the intrinsic alveolar epithelial dysfunction at the inception of interstitial lung disease
K.-D. Alysandratos, S. J. Russo, … D. N. Kotton·bioRxiv·Nov 13, 2020